Lymphocyte subsets in schizophrenic disorders. relationship with clinical, neuromorphological and treatment variables

Cinzia Masserini; Antonio Vita; Roberto Basile; Raffaele Morselli; Paolo Boato; Cinzia Peruzzi; Luigi Pugnetti; Pasquale Ferrante; Carlo Lorenzo Cazzullo

doi:10.1016/0920-9964(90)90008-U

Lymphocyte subsets in schizophrenic disorders. relationship with clinical, neuromorphological and treatment variables

Cinzia Masserini, Antonio Vita, Roberto Basile, Raffaele Morselli, Paolo Boato, Cinzia Peruzzi, Luigi Pugnetti, Pasquale Ferrante, Carlo Lorenzo Cazzullo

Fondazione Don Carlo Gnocchi Onlus

Research output: Contribution to journal › Article › peer-review

Abstract

Peripheral blood lymphocyte subsets and serum immunoglobulin levels were assessed in 42 patients and 37 healthy controls. 24 patients were free from neuroleptic medication and 15 had never been treated with neuroleptics. 31 patients had a diagnosis of schizophrenia (DSM-III criteria) and 11 a diagnosis of a disorder of the schizophrenic spectrum. As compared to healthy subjects, the drug naive schizophrenic patient group showed an increase of T suppressor lymphocytes, while the drug-treated schizophrenic group showed an increase of T helper lymphocytes. The drug-treated schizophrenic group differed from the drug naive one relative to a decrease of T suppressor lymphocytes. As compared to healthy subjects, the drug naive spectrum disorder patients showed an increase of absolute number of lymphocytes, while the drug treated spectrum group showed an increase of B lymphocytes. These findings did not correlate with any clinical or neuromorphological variables taken into account.

Original language	English
Pages (from-to)	269-275
Number of pages	7
Journal	Schizophrenia Research
Volume	3
Issue number	4
DOIs	https://doi.org/10.1016/0920-9964(90)90008-U
Publication status	Published - 1990

Keywords

Immunoglobubin
Lymphocyte subset
Neuroleptic side effect
Schizophrenic disorder

ASJC Scopus subject areas

Psychiatry and Mental health
Behavioral Neuroscience
Biological Psychiatry
Neurology
Psychology(all)

Access to Document

10.1016/0920-9964(90)90008-U

Fingerprint Dive into the research topics of 'Lymphocyte subsets in schizophrenic disorders. relationship with clinical, neuromorphological and treatment variables'. Together they form a unique fingerprint.

Cite this

Lymphocyte subsets in schizophrenic disorders. relationship with clinical, neuromorphological and treatment variables. / Masserini, Cinzia; Vita, Antonio; Basile, Roberto; Morselli, Raffaele; Boato, Paolo; Peruzzi, Cinzia; Pugnetti, Luigi; Ferrante, Pasquale; Cazzullo, Carlo Lorenzo.

In: Schizophrenia Research, Vol. 3, No. 4, 1990, p. 269-275.

Research output: Contribution to journal › Article › peer-review

@article{3e39e7b453aa4e328f78e2f7386d1fe1,

title = "Lymphocyte subsets in schizophrenic disorders. relationship with clinical, neuromorphological and treatment variables",

abstract = "Peripheral blood lymphocyte subsets and serum immunoglobulin levels were assessed in 42 patients and 37 healthy controls. 24 patients were free from neuroleptic medication and 15 had never been treated with neuroleptics. 31 patients had a diagnosis of schizophrenia (DSM-III criteria) and 11 a diagnosis of a disorder of the schizophrenic spectrum. As compared to healthy subjects, the drug naive schizophrenic patient group showed an increase of T suppressor lymphocytes, while the drug-treated schizophrenic group showed an increase of T helper lymphocytes. The drug-treated schizophrenic group differed from the drug naive one relative to a decrease of T suppressor lymphocytes. As compared to healthy subjects, the drug naive spectrum disorder patients showed an increase of absolute number of lymphocytes, while the drug treated spectrum group showed an increase of B lymphocytes. These findings did not correlate with any clinical or neuromorphological variables taken into account.",

keywords = "Immunoglobubin, Lymphocyte subset, Neuroleptic side effect, Schizophrenic disorder",

author = "Cinzia Masserini and Antonio Vita and Roberto Basile and Raffaele Morselli and Paolo Boato and Cinzia Peruzzi and Luigi Pugnetti and Pasquale Ferrante and Cazzullo, {Carlo Lorenzo}",

year = "1990",

doi = "10.1016/0920-9964(90)90008-U",

language = "English",

volume = "3",

pages = "269--275",

journal = "Schizophrenia Research",

issn = "0920-9964",

publisher = "Elsevier B.V.",

number = "4",

}

TY - JOUR

T1 - Lymphocyte subsets in schizophrenic disorders. relationship with clinical, neuromorphological and treatment variables

AU - Masserini, Cinzia

AU - Vita, Antonio

AU - Basile, Roberto

AU - Morselli, Raffaele

AU - Boato, Paolo

AU - Peruzzi, Cinzia

AU - Pugnetti, Luigi

AU - Ferrante, Pasquale

AU - Cazzullo, Carlo Lorenzo

PY - 1990

Y1 - 1990

N2 - Peripheral blood lymphocyte subsets and serum immunoglobulin levels were assessed in 42 patients and 37 healthy controls. 24 patients were free from neuroleptic medication and 15 had never been treated with neuroleptics. 31 patients had a diagnosis of schizophrenia (DSM-III criteria) and 11 a diagnosis of a disorder of the schizophrenic spectrum. As compared to healthy subjects, the drug naive schizophrenic patient group showed an increase of T suppressor lymphocytes, while the drug-treated schizophrenic group showed an increase of T helper lymphocytes. The drug-treated schizophrenic group differed from the drug naive one relative to a decrease of T suppressor lymphocytes. As compared to healthy subjects, the drug naive spectrum disorder patients showed an increase of absolute number of lymphocytes, while the drug treated spectrum group showed an increase of B lymphocytes. These findings did not correlate with any clinical or neuromorphological variables taken into account.

AB - Peripheral blood lymphocyte subsets and serum immunoglobulin levels were assessed in 42 patients and 37 healthy controls. 24 patients were free from neuroleptic medication and 15 had never been treated with neuroleptics. 31 patients had a diagnosis of schizophrenia (DSM-III criteria) and 11 a diagnosis of a disorder of the schizophrenic spectrum. As compared to healthy subjects, the drug naive schizophrenic patient group showed an increase of T suppressor lymphocytes, while the drug-treated schizophrenic group showed an increase of T helper lymphocytes. The drug-treated schizophrenic group differed from the drug naive one relative to a decrease of T suppressor lymphocytes. As compared to healthy subjects, the drug naive spectrum disorder patients showed an increase of absolute number of lymphocytes, while the drug treated spectrum group showed an increase of B lymphocytes. These findings did not correlate with any clinical or neuromorphological variables taken into account.

KW - Immunoglobubin

KW - Lymphocyte subset

KW - Neuroleptic side effect

KW - Schizophrenic disorder

UR - http://www.scopus.com/inward/record.url?scp=0025351623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025351623&partnerID=8YFLogxK

U2 - 10.1016/0920-9964(90)90008-U

DO - 10.1016/0920-9964(90)90008-U

M3 - Article

C2 - 1980614

AN - SCOPUS:0025351623

VL - 3

SP - 269

EP - 275

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 4

ER -